TABLE OF CONTENTS
1 MARKET INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
2.1 OVERVIEW
2.2 DATA FLOW
2.2.1 DATA MINING PROCESS
2.3 PURCHASED DATABASE:
2.4 SECONDARY SOURCES:
2.4.1 SECONDARY RESEARCH DATA FLOW:
2.5 PRIMARY RESEARCH:
2.5.1 PRIMARY RESEARCH DATA FLOW:
2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
2.6.1 REVENUE ANALYSIS APPROACH
2.7 DATA FORECASTING
2.7.1 DATA FORECASTING TECHNIQUE
2.8 DATA FORMULATIONLING
2.8.1 MICROECONOMIC FACTOR ANALYSIS:
2.8.2 DATA FORMULATIONLING:
2.9 TEAMS AND ANALYST CONTRIBUTION
3 MARKET DYNAMICS
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES
3.2.2 RISING AWARENESS OF INFECTION CONTROL MEASURES
3.3 RESTRAINTS
3.3.1 COST CONSTRAINTS IN INFECTION CONTROL
3.4 OPPORTUNITY
3.4.1 GROWING DEMAND FOR TECHNOLOGICALLY ADVANCED AND SUSTAINABLE INFECTION CONTROL SOLUTIONS
4 MARKET FACTOR ANALYSIS
4.1 VALUE CHAIN ANALYSIS
4.1.1 R&D
4.1.2 MANUFACTURING
4.1.3 DISTRIBUTION AND SALES
4.1.4 POST-SALES MONITORING
4.2 PORTER’S FIVE FORCES MODEL
4.2.1 THREAT OF NEW ENTRANTS
4.2.2 BARGAINING POWER OF SUPPLIERS
4.2.3 THREAT OF SUBSTITUTES
4.2.4 BARGAINING POWER OF BUYERS
4.2.5 INTENSITY OF RIVALRY
4.3 IMPACT OF COVID-19 ON THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
4.3.1 IMPACT ON SUPPLY CHAIN
4.3.2 IMPACT ON MARKET PLAYERS
5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 DISINFECTION PRODUCTS
5.2.1 LIQUID DISINFECTANTS
5.2.2 DISINFECTANT WIPES
5.2.3 DISINFECTANT SPRAYS
5.2.4 OTHERS
5.3 PERSONAL PROTECTIVE EQUIPMENT (PPE)
5.3.1 GLOVES
5.3.2 MASKS
5.3.3 GOWNS
5.3.4 PROTECTIVE EYEWEAR
5.3.5 OTHERS
5.4 STERILIZATION EQUIPMENT
5.4.1 HEAT STERILIZATION EQUIPMENT
5.4.2 LOW-TEMPERATURE STERILIZATION EQUIPMENT
5.4.3 RADIATION STERILIZATION EQUIPMENT
5.4.4 FILTRATION STERILIZATION EQUIPMENT
5.4.5 OTHERS
6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE
6.1 OVERVIEW
6.2 VIRAL
6.3 BACTERIAL
6.4 PARASITIC
6.5 FUNGAL INFECTIONS
7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER
7.1 OVERVIEW
7.2 HUMAN HEALTHCARE FACILITIES
7.2.1 HOSPITALS & CLINICS
7.2.2 AMBULATORY SURGICAL CENTERS
7.2.3 OTHERS
7.3 ANIMAL HEALTHCARE FACILITIES
7.3.1 VETERINARY HOSPITALS
7.3.2 ANIMAL SHELTERS
7.3.3 FARMING FACILITIES
7.3.4 OTHERS
8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 US
8.2.2 CANADA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 UK
8.3.4 ITALY
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 CHINA
8.4.2 INDIA
8.4.3 JAPAN
8.4.4 AUSTRALIA
8.4.5 SOUTH KOREA
8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD
8.5.2 MIDDLE EAST & AFRICA
8.5.3 SOUTH AMERICA
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2022
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT LAUNCH
10 COMPANY PROFILE
10.1 3M
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 ZOETIS ANIMAL HEALTHCARE
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 SWOT ANALYSIS
10.2.6 KEY STRATEGIES
10.3 PEROTECH SCIENCES INC.
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIES
10.4 STERIS PLC
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGY
10.5 GETINGE AB
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGY
10.6 VIROX TECHNOLOGIES, INC.
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIES
10.7 ADVANCED STERILIZATION PRODUCTS
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIES
10.8 NEOGEN CORPORATION
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 CARDINAL HEALTH
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIES
10.10 STRYKER
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LIQUID DISINFECTANTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT WIPES, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT SPRAYS, BY REGION, 2019–2032 (USD MILLION)
TABLE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY REGION, 2019–2032 (USD MILLION)
TABLE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GLOVES, BY REGION, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY MASKS, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GOWNS, BY REGION, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PROTECTIVE EYEWEAR, BY REGION, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 18 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HEAT STERILIZATION EQUIPMENT, BY REGION, 2019–2032 (USD MILLION)
TABLE 19 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY REGION, 2019–2032 (USD MILLION)
TABLE 20 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY RADIATION STERILIZATION EQUIPMENT, BY REGION, 2019–2032 (USD MILLION)
TABLE 21 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FILTRATION STERILIZATION EQUIPMENT, BY REGION, 2019–2032 (USD MILLION)
TABLE 22 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 23 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019–2032 (USD MILLION)
TABLE 24 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VIRAL, BY REGION, 2019–2032 (USD MILLION)
TABLE 25 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY BACTERIAL, BY REGION, 2019–2032 (USD MILLION)
TABLE 26 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PARASITIC, BY REGION, 2019–2032 (USD MILLION)
TABLE 27 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FUNGAL INFECTIONS, BY REGION, 2019–2032 (USD MILLION)
TABLE 28 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 29 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 30 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019–2032 (USD MILLION)
TABLE 31 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD MILLION)
TABLE 32 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 33 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 34 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 35 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019–2032 (USD MILLION)
TABLE 36 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VETERINARY HOSPITALS, BY REGION, 2019–2032 (USD MILLION)
TABLE 37 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL SHELTERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 38 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FARMING FACILITIES, BY REGION, 2019–2032 (USD MILLION)
TABLE 39 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 40 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 41 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 42 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 43 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 44 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 45 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 46 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019–2032 (USD MILLION)
TABLE 47 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 48 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 49 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 50 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 51 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 52 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 53 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 54 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019–2032 (USD MILLION)
TABLE 55 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 56 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 57 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 58 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 59 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 60 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 61 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 62 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019–2032 (USD MILLION)
TABLE 63 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 64 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 65 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 66 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 67 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 68 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 69 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 70 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 71 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019–2032 (USD MILLION)
TABLE 72 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 73 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 74 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019–2032 (USD MILLION)
TABLE 75 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 76 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 201